← Leaderboards
Jang-Ho J Cha
Massachusetts General Hospital
$4,558,946
Attributed
$4,558,946
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $572.4K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$4,558,946 · 5
By mechanism
R01$2,948,823 · 1
P01$1,045,168 · 1
M01$416,204 · 1
K08$113,751 · 1
R13$35,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Dimitri Krainc$24,610,296
- Hua-Ying Fan$3,825,645
- Rajiv R Ratan$8,541,580
- Toshihiro Shioda$10,202,413
- Ruth Luthi-Carter$1,045,169
Others in their field
Top investigators on “Gene Mutation”
- Richard A Gibbs · Baylor College Of Medicine$176,620,766
- David Heimbrook · Leidos Biomedical Research, Inc.$153,133,561
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Eric Martin McDade · Washington University$94,632,845
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$90,831,407
- Leonard Freedman · Leidos Biomedical Research, Inc.$79,171,841
Research focus
Gene MutationClinical ResearchDisease /Disorder ModelLaboratory MouseGenetically Modified AnimalsGlutamate ReceptorHuntington'S DiseaseTranscription FactorGenetic TranscriptionPurinergic ReceptorDopamine ReceptorPathologic ProcessPhenotypeNeurotransmitter ReceptorChromatin ImmunoprecipitationGenesPhosphorylationIn Situ HybridizationHuntington DiseaseGene ExpressionMutantBrain Disorder ChemotherapyHistonesHuman Tissue
Grant awards (17)
2009 CAG Triplet Repeat Disorders Gordon Research Conference$35,000
R13 · FY2009 · NS · contact PI
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE$345,345
R01 · FY2008 · NS · contact PI
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE$345,345
R01 · FY2007 · NS · contact PI
Chromatin remodeling in transgenic mouse models of Huntington's Disease$200,907
P01 · FY2007 · NS · contact PI
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE$355,660
R01 · FY2006 · NS · contact PI
Chromatin remodeling in transgenic mouse models of HD$210,572
P01 · FY2006 · NS · contact PI
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE$364,219
R01 · FY2005 · NS
Chromatin remodeling in transgenic mouse models of HD$208,189
P01 · FY2005 · NS
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTON'S DISEASE$363,179
R01 · FY2004 · NS
Chromatin remodeling in transgenic mouse models of HD$208,044
P01 · FY2004 · NS
Chromatin remodeling in transgenic mouse models of HD$217,456
P01 · FY2003 · NS
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTONS DISEASE$444,026
R01 · FY2002 · NS
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTONS DISEASE$423,771
R01 · FY2001 · NS
DOSE RANGE STUDY OF REMACEMIDE AS ADJUNCT TO LEVODOPA IN PARKINSON'S DISEASE$415,629
M01 · FY2000 · RR
RECEPTOR GENE TRANSCRIPTION IN HUNTINGTONS DISEASE$307,278
R01 · FY2000 · NS
METABOTROPIC RECEPTORS AND EXCITOTOXICITY$113,751
K08 · FY2000 · NS
DOSE RANGE STUDY OF REMACEMIDE AS ADJUNCT TO LEVODOPA IN PARKINSON'S DISEASE$575
M01 · FY2000 · RR